Cargando…
Mechanism of new optimized Sheng-Mai-San Formula to regulate cardiomyocyte apoptosis through NMDAR pathway
BACKGROUND AND OBJECTIVES: Ischemic heart failure (HF) has become a disease that seriously endangers people's life and health. As a herbal formula widely used in clinical practice, new optimized Sheng-Mai-San (NO-SMS) has been shown to be significantly effective in improving cardiac function, i...
Autores principales: | Hou, Yazhu, He, Zixun, Han, Yixiao, Zhang, Tongyan, Wang, Shuai, Wang, Xianliang, Mao, Jingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320033/ https://www.ncbi.nlm.nih.gov/pubmed/37416647 http://dx.doi.org/10.1016/j.heliyon.2023.e16631 |
Ejemplares similares
-
Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
por: Pang, Bing, et al.
Publicado: (2019) -
ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021) -
Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice
por: Chai, Cheng-Zhi, et al.
Publicado: (2016) -
YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
por: Zhao, Yichao, et al.
Publicado: (2016) -
Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1
por: Meng, Peina, et al.
Publicado: (2023)